StockData
AC Immune SA logo

AC Immune SA (ACIU) stock

ACIUNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 13, 2026Score 3/30
$2.13−0.01 (-0.47%)

Close on Nov 13, 2026Market cap $216.71MP/E –Yield –

AC Immune total assets

Total assets on the balance sheet at the end of each period.

AC Immune's total assets was CHF 150.40M at Jun 30, 2026. For fiscal 2025 it was CHF 154.25M, down 33.2% from the year before. The highest annual figure on record is CHF 299.25M in fiscal 2019.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025CHF 154.25M-33.2%
FY2024Dec 31, 2024CHF 230.91M+26.3%
FY2023Dec 31, 2023CHF 182.81M-1.7%
FY2022Dec 31, 2022CHF 185.94M-28.9%
FY2021Dec 31, 2021CHF 261.44M+9.5%
FY2020Dec 31, 2020CHF 238.74M-20.2%
FY2019Dec 31, 2019CHF 299.25M+52.2%
FY2018Dec 31, 2018CHF 196.56M+48.9%
FY2017Dec 31, 2017CHF 132.01M-15.4%
FY2016Dec 31, 2016CHF 156.10M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026CHF 150.40M-36.7%
Q4 FY2025Dec 31, 2025CHF 154.25M-15.6%
Q2 FY2025Jun 30, 2025CHF 190.22M+21.8%
Q4 FY2024Dec 31, 2024CHF 230.91M+24.2%
Q2 FY2024Jun 30, 2024CHF 237.54M+15.6%
Q4 FY2023Dec 31, 2023CHF 182.81M-30.1%
Q2 FY2023Jun 30, 2023CHF 156.23M-34.6%
Q4 FY2022Dec 31, 2022CHF 185.94M-37.9%
Q3 FY2022Sep 30, 2022CHF 205.56M+4.6%
Q4 FY2021Dec 31, 2021CHF 261.44M+98.0%
Q4 FY2020Dec 31, 2020CHF 238.74M+52.9%
Q4 FY2019Dec 31, 2019CHF 299.25M–
Q4 FY2018Dec 31, 2018CHF 196.56M–
Q4 FY2017Dec 31, 2017CHF 132.01M–
Q4 FY2016Dec 31, 2016CHF 156.10M–

More AC Immune figures

See a number that looks wrong?